Page last updated: 2024-09-05

17 alpha-hydroxyprogesterone caproate and HIV Infections

17 alpha-hydroxyprogesterone caproate has been researched along with HIV Infections in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's3 (75.00)2.80

Authors

AuthorsStudies
Ntozini, R; Prendergast, AJ1
Chomba, E; Cole, SR; Freeman, BL; Goldenberg, RL; Kasaro, MP; Mbewe, FM; Muyangwa, D; Mwape, H; Peterson, M; Phiri, WM; Price, JT; Rouse, DJ; Saha, PT; Sindano, N; Smithmyer, ME; Stringer, JSA; Vwalika, B1
Cole, SR; Conner, MG; Freeman, BL; Kasaro, MP; Mabula-Bwalya, CM; Price, JT; SebastiĆ£o, YV; Stringer, EM; Stringer, JSA; Vwalika, B1
Chomba, E; Cole, SR; Freeman, BL; Goldenberg, RL; Mbewe, FM; Mofenson, LM; Mulenga, HB; Price, JT; Rouse, DJ; Stringer, JSA; Vwalika, B; Winston, J1

Trials

3 trial(s) available for 17 alpha-hydroxyprogesterone caproate and HIV Infections

ArticleYear
Weekly 17 alpha-hydroxyprogesterone caproate to prevent preterm birth among women living with HIV: a randomised, double-blind, placebo-controlled trial.
    The lancet. HIV, 2021, Volume: 8, Issue:10

    Topics: 17 alpha-Hydroxyprogesterone Caproate; Adolescent; Double-Blind Method; Female; Gestational Age; HIV Infections; Humans; Infant, Newborn; Pregnancy; Premature Birth; Zambia

2021
Effect of weekly 17-hydroxyprogesterone caproate on small for gestational age among pregnant women with HIV in Zambia.
    AIDS (London, England), 2022, 11-15, Volume: 36, Issue:14

    Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Female; Gestational Age; HIV Infections; Humans; Hydroxyprogesterones; Infant; Pregnancy; Pregnant Women; Premature Birth; Zambia

2022
Intramuscular 17-hydroxyprogesterone caproate to prevent preterm birth among HIV-infected women in Zambia: study protocol of the IPOP randomized trial.
    BMC pregnancy and childbirth, 2019, Feb-27, Volume: 19, Issue:1

    Topics: 17 alpha-Hydroxyprogesterone Caproate; Anti-HIV Agents; Clinical Trials, Phase III as Topic; Developing Countries; Female; Gestational Age; HIV Infections; Humans; Injections, Intramuscular; Live Birth; Pregnancy; Pregnancy Complications, Infectious; Premature Birth; Progestins; Randomized Controlled Trials as Topic; Stillbirth; Zambia

2019

Other Studies

1 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and HIV Infections

ArticleYear
17 alpha-hydroxyprogesterone caproate, HIV, and preterm birth.
    The lancet. HIV, 2021, Volume: 8, Issue:10

    Topics: 17 alpha-Hydroxyprogesterone Caproate; Gestational Age; HIV Infections; Humans; Infant, Newborn; Premature Birth

2021